A
Description
Maker of active pharmaceutical ingredients and advanced intermediates with over twenty years of activity and three Telangana plants — Pashamylaram, Veliminedu and Yavapur — plus an R&D centre. Its portfolio is markedly antiretroviral — dolutegravir, tenofovir, emtricitabine, efavirenz, ritonavir, bictegravir — and also covers anti-TB products such as bedaquiline and pretomanid, plus CNS molecules. States twenty-four new products a year.